$KEQU

KEWAUNEE SCIENTIFIC CORP /DE/

Insider trades

No enriched coverage for $KEQU in the last 7 days.

No SEC Form 4 filings for $KEQU in the last 30 days.

See all $KEQU insider activity →

KEQU sentiment & insider activity

Recent KEQU coverage spans insider activity, financial news and earnings.

What's driving KEQU

  • Routine insider sale to issuer (likely buyback participation) with no 10b5-1 plan disclosed; limited signal for fundamentals.

    SEC EDGAR · Jul 2, 2026

  • Routine insider sale to the issuer (buyback participation) with no 10b5-1 plan; likely limited signal value.

    SEC EDGAR · Jul 2, 2026

  • A routine insider sale to the issuer (buyback participation) with no 10b5-1 plan disclosed; likely limited signal value but can affect near-term sentiment.

    SEC EDGAR · Jul 2, 2026

  • Routine insider sale to the issuer (buyback participation) with no stated 10b5-1 plan; modest signal for near-term sentiment rather than fundamentals.

    SEC EDGAR · Jul 2, 2026

  • Routine insider sale to issuer (buyback participation) with no 10b5-1 plan stated; likely limited signal value but can affect near-term sentiment.

    SEC EDGAR · Jul 2, 2026

alphai scores every news story that mentions KEQU with an AI model for sentiment and relevance, and aggregates insider trades from KEWAUNEE SCIENTIFIC CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KEQU

Score
$KEQUMed

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU): Results of Operations and Financial Condition

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ

$KEQULow

Kewaunee Scientific stock (US4925721028): Recent financial metrics and market position

Kewaunee Scientific (KEQU) reported a quarterly net other income/expense of -$978,000, representing a 0.31% year-over-year decline. The company, which specializes in laboratory furniture and equipment, traded at $36.73 with a market capitalization of $105.28 million as of May 2026. This update provides insights into the financial dynamics and market position of the NYSE-listed firm for US investors.

$KEQUMed

Lab furniture maker Kewaunee to post Q3 results on March 11

Kewaunee Scientific Corporation (NASDAQ: KEQU) announced that it will release its third-quarter fiscal year 2026 financial results after market close on Wednesday, March 11, 2026. The results will be posted on the company's website and will include information on its expanded footprint, such as the Nu Aire acquisition and its multi-country manufacturing network. The announcement also highlighted the company's historical stock movement around earnings notice dates.

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

Kewaunee Scientific Corporation announced it will release its third-quarter fiscal year 2026 financial results on Wednesday, March 11, 2026, after the close of trading, with information available on its website. The company, a global leader in laboratory and healthcare furniture, also highlighted its recent acquisition of Nu Aire, a manufacturer of essential laboratory products. The press release includes forward-looking statements and information about its risks and operations.

Related tickers